PharmaShots Weekly Snapshot (Jun 08- 12, 2020)

 1. Medtronic Receives CE Mark for MiniMed 780G Insulin Pump to Treat Type 1 Diabetes                                               

Published: Jun 11, 2020 | Tags: Medtronic, Receives, CE, Mark, MiniMed 780G, Insulin Pump, Treat, Type 1 Diabetes

2.  Takeda to Divest OTC and Select Non-core Assets to Celltrion for ~ $278M       

Published: Jun 11, 2020 | Tags: Takeda, Divest, OTC, Select Non-core, Assets, Celltrion ~ $278M

 3. Regeneron Initiates its First Clinical Study of Antibody Cocktail for the Treatment and Prevention of COVID-19

Published: Jun 11, 2020 | Tags: Regeneron, Initiates, First, Clinical Study, Antibody Cocktail, Treatment, Prevention, COVID-19

4.  Lannett to Submit Biosimilar Application to the US FDA for its Insulin Glargine by the End of 2022

Published: Jun 11, 2020 | Tags: US, FDA, Advances, Lannett, Program, Biosimilar, Insulin Glargine

5. Moderna to Initiate P-III Study of its mRNA-1273 Against COVID-19 in July 2020

Published: Jun 11, 2020 | Tags: Moderna, Initiate, P-III, Study, mRNA-1273, Against, COVID-19, July, 2020

6.  Mylan and Biocon Receive the US FDA’s Approval for Semglee (biosimilar, insulin glargine)

Published: Jun 11, 2020 | Tags: Mylan, Biocon, Receive, US, FDA, Approval, Semglee, insulin glargine injection

7.  Novo Nordisk to Acquire AstraZeneca’s Spin-off Corvidia for ~$2.1B

Published: Jun 11, 2020 | Tags: Novo Nordisk, Acquire, Corvidia, ~$2.1B

8.  Celltrion to Evaluate Remsima (biosimilar, infliximab) Against COVID-19 in the UK

Published: Jun 10, 2020 | Tags: Celltrion, Evaluate, Remsima, biosimilar, infliximab, Against, COVID-19, Britain

9. Pfizer Receives the US FDA’s Approval for its Nyvperia (biosimilar, pegfilgrastim)

Published: Jun 11, 2020 | Tags: Pfizer, Receives, US, FDA, Approval, Nyvperia, biosimilar, pegfilgrastim

10.  Sorrento Submits EUA to the US FDA for its COVI-TRACK Test to Detect COVID-19

Published: Jun 10, 2020 | Tags: Sorrento, Submits, EUA, US, FDA, COVI-TRACK Test, Detect, COVID-19

11.  BMS’ Opdivo (nivolumab) Receives the US FDA’s Approval for Advanced Esophageal Squamous Cell Carcinoma

Published: Jun 10, 2020 | Tags: BMS, Opdivo, nivolumab, Receives, US, FDA, Approval, Advanced, Esophageal Squamous Cell Carcinoma

12.  Cipla to Acquire 21.85% Stake in GoApptiv for ₹9 Crores

Published: Jun 10, 2020 | Tags: Cipla, Acquire, 21.85%, Stake, GoApptiv, ₹9 Crore

13.  RedHill Biopharma Reports the Submission of CTA for P-II/III Study Evaluating Opaganib Against COVID-19 in Russia

Published: Jun 10, 2020 | Tags: RedHill Biopharma, Reports, Submission, CTA, P-II/III, Study, Evaluating, Opaganib, Against, COVID-19, Russia

14.   Johnson & Johnson to Initiate P-I/IIa Clinical Study of its COVID-19 Vaccine in July

Published: Jun 10, 2020 | Tags: Johnson & Johnson, Initiate, P-I/IIa, Clinical Study, COVID-19, Vaccine, July

15.   Dexcom’s Glucose Monitoring Wearable System Receives CE Mark in the Europe

Published: Jun 09, 2020 | Tags: Dexcom, Glucose Monitoring, Wearable System, Receives, CE Mark, Europe

16.   Takeda Signs an Exclusive License and Research Agreement with Debiopharm to Develop Novel Microbiome Therapeutics for the Gastrointestinal Disorders

Published: Jun 09, 2020 | Tags: Takeda, Signs, Exclusive, License, Research Agreement, Debiopharm, Develop, Novel Microbiome Therapies, Gastrointestinal Disorders

17.  BMS Signs a Clinical Trial Collaboration with UbiVac to Evaluate the Triplet Therapy for Advanced Triple Negative Breast Cancer

Published: Jun 09, 2020 | Tags: BMS, Signs, Clinical Trial Collaboration, UbiVac, Evaluate, Triplet Therapy, Advanced, Triple Negative Breast Cancer

18.  AbbVie Collaborates with Genmab to Develop and Commercialize Therapies for Cancer Worth Over $3B

Published: Jun 09, 2020 | Tags: AbbVie, Collaborates, Genmab, Develop, Commercialize Therapies, Cancer, Worth Over $3B

19.   AstraZeneca Plans to Advance the Combination of Neutralizing Antibody for COVID-19 into Clinical in Next Two Months

Published: Jun 09, 2020 | Tags: AstraZeneca, Advance, Combination, Neutralizing, Antibody, Against, COVID-19

20.  Sandoz Receives Health Canada’s Approval to Launch Ziextenzo (biosimilar, pegfilgrastim) and Riximyo (biosimilar, rituximab) in Canada

Published: Jun 09, 2020 | Tags: Sandoz, Receives, Health Canada, Approval, Launch, Ziextenzo, biosimilar, pegfilgrastim, Riximyo, biosimilar, rituximab

21.  Denali and Sanofi Provide Update on its RIPK1 Program

Published: Jun 10, 2020 | Tags: Denali, Sanofi, Provide, Update, RIPK1 Program

22.  Eli Lilly Signs Five-Years License Agreement with Evox Therapeutics for its DeliverEX Platform

Published: Jun 09, 2020 | Tags: Eli Lilly, Signs, Five-Years, License Agreement, Evox Therapeutics,  DeliverEX Platform

23.  Eli Lilly Reports Dosing of its First Patient with Tirzepatide in P-III SURPASS-CVOT Study for Cardiovascular Outcomes

Published: Jun 09, 2020 | Tags:  Eli Lilly, Reports, Dosing, First Patient, Tirzepatide, P-III, SURPASS-CVOT, Study, Cardiovascular Outcomes

24.  Mallinckrodt Reports Completion of BLA Submission to the US FDA for StrataGraft to Treat Deep Partial-Thickness Thermal Burns in Adults

Published: Jun 09, 2020 | Tags: Mallinckrodt, Reports, Completion, BLA, Submission, US, FDA, StrataGraft, Treat, Deep, Partial-Thickness Thermal Burns, Adults

25.   Astellas Reports Results of Roxadustat in P-III DOLOMITES Study to Treat Anemia in Non-Dialysis Dependent Adult Patients with Chronic Kidney Disease

Published: Jun 09, 2020 | Tags: Astellas, Reports, Results, Roxadustat, P-III, DOLOMITES Study,  Treat, Anemia,  Non-Dialysis, Dependent, Adult Patients, Chronic Kidney Disease

26.   Alphamab Oncology Signs an Agreement with Sanofi for KN026

Published: Jun 09, 2020 | Tags: Alphamab Oncology, Signs, Agreement, Sanofi, KN026

25..Eli Lilly to Initiate P-I Study of its Second Antibody Treatment Against COVID-19

Published: Jun 08, 2020 | Tags: Eli Lilly, Initiate, P-I, Study, Second, Antibody Treatment, Against, COVID-19

26.   Oxford Biomedica Signs a Five-Year Agreement with the Vaccines Manufacturing and Innovation Centre (VMIC) for AZD1222

Published: Jun 08, 2020 | Tags: Oxford Biomedica, Signs, Five-Year Agreement, Vaccines Manufacturing and Innovation Centre, VMIC, AZD1222

27.  AbbVie Enters into a Collaboration to Develop Monoclonal Antibody Therapy for Preventing COVID-19

Published: Jun 08, 2020 | Tags: AbbVie, Enters, Collaboration, Develop, Monoclonal Antibody Therapy, Preventing, COVID-19

28.  AstraZeneca in Talks with Gilead for a Megamerger

Published: Jun 08, 2020 | Tags: AstraZeneca, Talks, Gilead, Megamerger

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post